Angiopoietin-1 mRNA and Bcl-2 expression following estradiol treatment in ovariectomized rats with focal cerebral ischemia/reperfusion injury*
Publisher:baiylzxc Publish Time:Tuesday, October 13, 2009 Source:Neural Regen Res,2009,4(10),780-785 |
Rong Gu1, Minghua Liu2, Yonghong Wang3, Yuanda Zhou4, Haixia He4
1Department of Pharmacy, Children’s Hospital of Chongqing Medical University, Chongqing 400016, China 2Department of Emergency, Southwest Hospital of Third Military Medical University, Chongqing 400016, China 3Chongqing Key Laboratory of Neurology, Department of Neurology, First Hospital of Chongqing Medical University, Chongqing 400016, China 4Research Laboratory of Bioengineering, Basic Medical School, Department of Clinical Pharmacology, First Hospital of Chongqing Medical University, Chongqing 400016, China
the Natural Science Foundation of Chongqing, No. CSTC2006EB5030*
Abstract BACKGROUND: Estrogen has been clinically demonstrated to attenuate ischemic brain injury. However, the precise mechanisms remain controversial. OBJECTIVE: To investigate the effects of estradiol on angiopoietin-1 mRNA and Bcl-2 expression, as well as apoptosis and cerebral blood flow, in ovariectomized rats with focal cerebral ischemia following reperfusion. DESIGN, TIME AND SETTING: Randomized, controlled, animal experiment. The study was per-formed at the Central Laboratory, Chongqing Medical University from September to December 2005. MATERIALS: Estradiol benzoate was purchased from Shanghai Ninth Pharmaceutical Factory; corn oil was purchased from Walmart Supercenter; TUNEL kit, rabbit anti-rat Bcl-2 polyclonal anti-body, and biotin-labeled goat anti-rabbit antibody were purchased from Wuhan Boster, China. METHODS: Healthy, female, 6-month-old Wistar rats–wild-type and estrogen alpha receptor gene knockout (ERKO)–were randomly divided into estradiol and control groups with 25 animals in each group. The rats were intramuscularly injected with estradiol benzoate (100 μg/kg per day) at 30 days following bilateral ovariectomy or corn oil (1 mL/kg per day) for seven consecutive days. Following administration, cerebral ischemia/reperfusion models were established using the right middle cere-bral artery occlusion (MCAO) method. After 30 minutes of MCAO, estradiol and control groups were separately injected with estradiol benzoate and corn oil with the above-mentioned doses. MAIN OUTCOME MEASURES: Cell apoptosis was determined by TUNEL; angiopoietin-1 mRNA and Bcl-2 gene expression was determined, respectively, by immunohistochemical staining and RT-PCR. In addition, changes in cerebral blood flow were measured by laser Doppler flowmetry. RESULTS: Changes in angiopoietin-1 mRNA and cerebral blood flow in estradiol-treated, wild-type, MCAO rats following ischemia/reperfusion were greater than in control rats (P < 0.01 or 0.05). However, no significant difference was observed between estradiol-treated ERKO MCAO rats and control rats. In addition, estradiol-treated wild-type and ERKO MCAO rats exhibited significantly in-creased Bcl-2 expression (P < 0.05) and decreased number of apoptotic cells in brain tissues compared with control groups (P < 0.05). CONCLUSION: Estradiol upregulated angiopoietin-1 mRNA and Bcl-2 expression, suggesting that estradiol might be involved in protective mechanisms of cerebral ischemia/reperfusion injury.
Key Words: estradiol; angiopoietin; apoptosis; Bcl-2; cerebral ischemia/reperfusion
Full Text: Click
|